Pharmacovigilance Services USA | DDReg Pharma

Pharmacovigilance Consulting Services in USA

Ensure FDA compliance, manage signals effectively, and reduce time-to-market with our Expert Drug Safety & Compliance Support for Life Sciences Companies

  • 24/7 ICSR Case Processing & Medical Review
  • QPPV & Local Person Responsible Services
  • Audit-Ready Quality Management Systems
  • Strategic Signal & Risk Management

Request a Consultation

Speak directly with a pharmacovigilance consultant today.

45k+

ICSR

480+

Aggregate Reports

750+

RMP

60+

ADCO/AASR

Why Choose DDReg Pharma as Your Pharmacovigilance Service Provider?

At DDReg, we specialize in customized pharmacovigilance consulting services tailored for pharmaceutical, biotech, and life sciences organizations in the United States.

ICSR Reporting Services

Comprehensive case intake, processing, medical review, and regulatory submission for post-marketing cases.

QPPV Services

Provision of Local QPPV and Deputy QPPV to ensure 24/7 compliance oversight.

Signal Management

Proactive signal detection, validation, and assessment to identify risks early using advanced safety databases.

PV Audit & Compliance

Mock inspections, gap analysis, and system audits to prepare you for FDA/EMA inspections.

Literature Monitoring

Comprehensive global and local literature screening to identify safety signals and ICSRs with high precision.

Aggregate Safety Reports Services

Expert preparation and submission of PSURs, PBRERs, and PADERs ensuring data integrity and medical accuracy.

Success Stories

QPPV Deployment Across 11 Countries for PV Compliance

To establish locally compliant QPPV presence across 11 markets within 30 days, build an inspection-ready pharmacovigilance framework integrated with the client’s global PV systems

Read Full Study →

PV System Audit Uncovers Gaps, Boosts Readiness

To ensure compliance, a systematic PV audit identified non-compliances, providing practical steps for inspection-readiness aligned with global pharmacovigilance expectations and standards.

Read Full Study →

Developing Pharmacovigilance Systems in the MENA Region

A MENA regulator addressed critical PV system gaps to boost drug safety monitoring for its product portfolio across the region, ensuring enhanced oversight and compliance.

Read Full Study →

Certifications & Standards

ISO 9001:2015 ISO 27001 (Data Security) 21 CFR Part 11 Compliant

"DDReg’s strong subject matter expertise has been a great support to our team, helping us ensure timely and accurate case submissions"

- Head of Pharmacovigilance, Top 10 US Biotech Firm

Our Seamless Onboarding Process

1

Gap Analysis

We conduct an initial audit of your current PV system to identify regulatory gaps and safety needs.

2

Strategic Setup

Deployment of QPPV, safety databases, and custom SOPs tailored to USA, EU, MENA, etc regulations.

3

Continuous Compliance

Ongoing ICSR processing, signal detection, and aggregate reporting to ensure inspection readiness 24/7.

Frequently Asked Questions

We can typically deploy a qualified QPPV or Local Person for Pharmacovigilance (LPPV) within 15 to 30 days, depending on the complexity and geographic requirements.
Yes, all our pharmacovigilance databases and quality management systems are fully compliant with 21 CFR Part 11 and EU Annex 11 standards to ensure data integrity.
Absolutely. We utilize industry-leading safety databases (like PV.EDGE ARGUS) and advanced signal detection tools to proactively monitor product safety profiles.